Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

GoodRx

Biotech & Life Sciences · Santa Monica, United States · Founded 2011 · IPO 2020 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.07B
Market cap · Apr/2026
Revenue
$797M
Latest reported FY

Investors

12 investors on GoodRx's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 10 investors entered at this stage
Francisco Partners
Dawn Lepore
SV Angel
Michael Ovitz
Highland Capital Partners
Soma Capital
Spectrum Equity
Upfront Ventures
Lerer Hippeau
Founders Fund
Series B+ 2 investors entered at this stage
Silver Lake Partners
TCV

Global footprint

Where GoodRx has talent and traffic

AI talent share
3.0% of workforce is AI talent
(33 of 1,093 staff)
Core AI50.46%
Other AI282.56%
Non-AI workforce1,06096.98%
Web traffic by country
21M monthly visits
across markets
🇺🇸 United States84.9%
🇨🇦 Canada3.4%
🇦🇺 Australia1.8%
🇮🇳 India1.8%
🇵🇭 Philippines0.7%
Top 5 markets shown

Patent intelligence

$340k patent portfolio · 3 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$340k
0.03% of market cap · 1.8× smaller than top peer Omada Health ($612k)
3 active patent families
Where GoodRx innovates DatabaseDrug productPharmacyDrug pricesIdentifying medications
Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

GoodRx on the five Patsnap quality dimensions

GoodRx in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where GoodRx concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across GoodRx and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See GoodRx on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo